The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention
Highlights
► We hypothesize that PTX3 may play a role in the development of insulin resistance in obese children. ► We performed cross-sectional study as well as intervention study to test our hypothesis. ► Cross-sectional study showed that PTX3 was negatively associated with insulin resistance. ► Delta PTX3 levels after the physical activity was associated with delta insulin resistance. ► PTX3 may play a role in the development of insulin resistance in obese children.
Introduction
Childhood obesity has increased significantly during the last decade and obesity associated with metabolic diseases such as cardiovascular disease and type 2 diabetes have become more prevalent among children [1], [2]. Inflammatory markers have been identified as one of main contributors for the development of obesity associated insulin resistance [3], [4], [5]. Exercise and physical activity are important to treat childhood obesity and obesity associated insulin resistance [6]. However, the exercise induced improvement of insulin resistance and its association with adipocytokines and/or inflammatory markers in children remained to be fully elucidated.
Pentraxin 3 (PTX3), a novel inflammatory marker, is a member of the long pentraxin family, a component of the humoral arm of innate immunity [7], [8]. Unlike the classic short pentraxin C-reactive protein (CRP), which is synthesized in the liver as a systemic response to local inflammation [9], PTX3 is produced rapidly in damaged tissue and may reflect more of a tissue-specific inflammatory response that includes smooth and skeletal muscle and adipocytes [10], [11], [12]. Although the role of PTX3 in the pathogenesis of atherosclerosis [13], [14] and heart failure [15] has been identified, studies still report conflicting data on the association of PTX3 with adiposity and insulin resistance in human among many different health conditions [14], [16], [17]. These conflicting reports on the relationship among PTX3, adiposity and insulin resistance could be due to the ages of the participants. Considering that PTX3 increases with the development of atherosclerosis, it might be more appropriate to investigate the relationship between PTX3, adiposity and insulin resistance in subjects without atherosclerosis but still have some degree of obesity [11], [13], [16]. Therefore, studying the relationship between PTX3 and obese children without atherosclerosis would be logical. In addition, most studies that reported an association between adiposity and circulating PTX3 levels have used body mass index (BMI) and waist circumference (WC) as an adiposity index. To completely understand the role of PTX3 in the development of obesity associated insulin resistance, the association of PTX3 with adiposity and insulin resistance should be investigated using more accurate adiposity measurements such as computed tomography (CT).
Physical activity decreases insulin resistance and also alters various adipocytokines including adiponectin, tumor necrosis factor-alpha and interleukin-6 [18], [19]. Fukuda et al. [20] and Nakajima et al. [21] recently reported changes in PTX3 levels after cardiac rehabilitation exercise and after high intensity aerobic and resistance exercise. However, the effects of exercise or short-term physical activity on PTX3 levels and its relationship to anthropometric, insulin resistance and metabolic parameters have not been studied. Therefore, the purpose of the study is to test whether 1) circulating PTX3 levels are associated with insulin resistance, anthropometric measurements and metabolic parameters and 2) whether 7 days of intense physical activity would alter PTX3 levels in association with changes in insulin resistance, anthropometric measurements and metabolic parameters.
Section snippets
Subject
Fifty‐seven overweight or obese elementary school students in the fourth, fifth or sixth grade participated in the study. All subjects were classified as either overweight or obese according to the criteria based on Korean Society for the Study of Obesity guidelines for children [22]. Subject characteristics are summarized in Table 1. This study was approved by the Institutional Ethics Review Board at Yonsei University College of Medicine, Wonju Campus. Written informed consent was obtained
PTX3 was not associated with adiposity but was significantly associated with whole body muscle mass and mid-thigh muscle mass (Fig. 1, Table 2)
There was no correlation between circulating PTX3 levels and any of the adiposity measurements including WC, percent body fat, VAT and SAT. However, there was a significant association between circulating PTX3 levels and whole body muscle mass and mid-thigh muscle mass. The association between circulating PTX3 and measurements of muscle mass remained statistically significant after controlling for gender, BMI and Tanner stage.
PTX3 was associated with plasma insulin levels, HOMA-IR and TG levels
Correlation coefficient analyses demonstrated that PTX3 levels were
Discussion
This reports the association between PTX3 and insulin resistance and the effects of short-term physical activity on circulating PTX3 levels and its association with insulin resistance in children. In the cross-sectional analyses, HOMA-IR was associated with PTX3 even after adjusting for age, gender, BMI and Tanner stage. Furthermore, the degree of changes in PTX3 levels were negatively associated with fasting and insulin and HOMA-IR, which provide evidence of the link between PTX3 and insulin
Disclosure statements
No author has anything to declare.
Acknowledgments
We appreciate Dr. Young Hee Lee and Mr. Sung Soo Jeon for their technical expertise and advice on measuring abdominal adiposity. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009‐0070217) and Sports ToTo.
References (40)
- et al.
Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells
J Lipid Res
(2003) - et al.
Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells
Atherosclerosis
(2004) - et al.
Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites
Blood
(1996) - et al.
Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure
Am Heart J
(2008) - et al.
Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents
J Pediatr
(2005) - et al.
Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification
Clin Chim Acta
(2010) - et al.
Prevalence of overweight and obesity in the United States, 1999–2004
JAMA
(2006) - et al.
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
N Engl J Med
(2002) - et al.
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB
Nat Med
(2005) - et al.
The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome
J Clin Res Pediatr Endocrinol
(2009)
Therapeutic approaches to target inflammation in type 2 diabetes
Clin Chem
Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth
Obesity
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility
Annu Rev Immunol
Complement dependent amplification of the innate response to a cognate microbial ligand by the long pentraxin PTX3
J Immunol
Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6
Hepatology
Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis
Circulation
Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile
Clin Exp Med
Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea
Am J Hypertens
Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease
Arthritis Care Res (Hoboken)
Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice
Am J Physiol Endocrinol Metab
Cited by (28)
Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role
2022, Biomedicine and PharmacotherapyCitation Excerpt :Additionally, PTX3 is higher in metabolic syndrome patients with subclinical atherosclerosis [307]. PTX3 level is negatively correlated with insulin resistance and changes in insulin resistance induced by physical activity in overweight and obese children [308]. In obese patients with NAFLD, compared with individuals with normal blood glucose levels, patients with prediabetes and type 2 diabetes mellitus (T2DM) had higher serum PTX3 level [309].
Pentraxin 3 is an anti-inflammatory protein associated with lipid-induced interleukin 10 in vitro
2016, CytokineCitation Excerpt :Thus, these findings provide additional evidence supporting the anti-inflammatory and athero-protective function of PTX3. Observations from this study are of particular interest for obese populations who present with decreased concentrations of plasma PTX3 and monocytes that are polarized towards an M1 phenotype [13,17,25–31], and further examination of the aforementioned responses in obese populations may provide additional insight into the clinical relevance of resting PTX3 concentrations. Consequently, additional studies are warranted to investigate the optimal in vitro and in vivo concentration of PTX3 necessary to correct inflammatory imbalances associated with PBMCs from individuals at risk for atherosclerosis and to elucidate the molecular targets specific to PTX3-induced IL-10 production.
Pentraxin 3 production in the adipose tissue and the skeletal muscle in diabetic-obese mice
2014, American Journal of the Medical SciencesCitation Excerpt :Because TSOD mice showed significantly higher blood and urine glucose levels and had decreased GLUT4 protein expression, we were able to confirm some of the characteristics of type 2 diabetes in this study. Osorio-Conles et al15 and Chu et al16 recently showed a significant negative correlation between plasma PTX3 levels and insulin resistance in lean, overweight and obese individuals. However, it has not been elucidated the precise role of PTX3 on insulin sensitivity.
Tumour response following preoperative chemotherapy is affected by body mass index in patients with colorectal liver metastases
2024, World Journal of Gastrointestinal OncologyThe relationship between metabolic syndrome criteria and pentraxin-3 levels in children
2023, Journal of Pediatric Endocrinology and Metabolism
- 1
Both authors contributed equally to this work.